CFO Venk Nathamuni reported adjusted EBITDA of $287 million, reflecting an 8% year-over-year growth, and an adjusted EBITDA margin of 13.4%. Consolidated backlog gross profit increased 15% ...

Private Equity focused on investment and operations within the Life Science industry faces significant compliance, operational and business risk ...